These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 27524470)

  • 1. Mapping the Resistance Potential of Influenza's H
    Assa D; Alhadeff R; Krugliak M; Arkin IT
    J Mol Biol; 2016 Oct; 428(20):4209-4217. PubMed ID: 27524470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Characterization of the Spectrum of Antiviral Activity and Genetic Barrier to Drug Resistance of M2-S31N Channel Blockers.
    Ma C; Zhang J; Wang J
    Mol Pharmacol; 2016 Sep; 90(3):188-98. PubMed ID: 27385729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel method of resistance for influenza against a channel-blocking antiviral drug.
    Astrahan P; Kass I; Cooper MA; Arkin IT
    Proteins; 2004 May; 55(2):251-7. PubMed ID: 15048819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
    Moorthy NS; Poongavanam V; Pratheepa V
    Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amantadine resistance among highly pathogenic avian influenza viruses (H5N1) isolated from India.
    Jacob A; Sood R; Chanu KhV; Bhatia S; Khandia R; Pateriya AK; Nagarajan S; Dimri U; Kulkarni DD
    Microb Pathog; 2016 Feb; 91():35-40. PubMed ID: 26639679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amantadine resistance among porcine H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany between 1981 and 2001.
    Schmidtke M; Zell R; Bauer K; Krumbholz A; Schrader C; Suess J; Wutzler P
    Intervirology; 2006; 49(5):286-93. PubMed ID: 16809934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of amantadine-resistance influenza a (H3N2) in six prefectures, Japan, in the 2005-2006 season.
    Saito R; Li D; Suzuki Y; Sato I; Masaki H; Nishimura H; Kawashima T; Shirahige Y; Shimomura C; Asoh N; Degawa S; Ishikawa H; Sato M; Shobugawa Y; Suzuki H
    J Med Virol; 2007 Oct; 79(10):1569-76. PubMed ID: 17705168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New strategy for high throughput screening of anti-influenza virus M2 ion channel inhibitors.
    Li C; Long Y; Lin Z; Jie Y; Xiao Y; Yang L; Sun J; Ren Y; Chen L; Li Z
    Curr Pharm Des; 2013; 19(28):5146-55. PubMed ID: 23621591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations.
    Abed Y; Goyette N; Boivin G
    Antimicrob Agents Chemother; 2005 Feb; 49(2):556-9. PubMed ID: 15673732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe.
    Pozo F; Lina B; Andrade HR; Enouf V; Kossyvakis A; Broberg E; Daniels R; Lackenby A; Meijer A;
    J Clin Virol; 2013 May; 57(1):5-12. PubMed ID: 23375738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug susceptibility of influenza A/H3N2 strains co-circulating during 2009 influenza pandemic: first report from Mumbai.
    Gohil DJ; Kothari ST; Shinde PS; Chintakrindi AS; Meharunkar R; Warke RV; Kanyalkar MA; Chowdhary AS; Deshmukh RA
    Infect Genet Evol; 2015 Jan; 29():75-81. PubMed ID: 25461259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential patterns of amantadine-resistance in influenza A (H3N2) and (H1N1) isolates in Toronto, Canada.
    Higgins RR; Eshaghi A; Burton L; Mazzulli T; Drews SJ
    J Clin Virol; 2009 Jan; 44(1):91-3. PubMed ID: 19019729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The matrix gene of influenza A H5N1 in Egypt, 2006-2016: molecular insights and distribution of amantadine-resistant variants.
    Naguib MM; Hagag N; El-Sanousi AA; Hussein HA; Arafa AS
    Virus Genes; 2016 Dec; 52(6):872-876. PubMed ID: 27448682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Resistance to amantadine of epidemic strain of H3 subtype influenza virus: a primary study].
    Xu H; Qian Y; Xu H; Zhang JH; Zhu RN; Wang F
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):996-8. PubMed ID: 16759544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and energetic analysis of drug inhibition of the influenza A M2 proton channel.
    Gu RX; Liu LA; Wei DQ
    Trends Pharmacol Sci; 2013 Oct; 34(10):571-80. PubMed ID: 24011996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of amantadine-resistant influenza A (H1N1 pdm09) virus isolated from slum dwellers of Dhaka, Bangladesh.
    Rahman M; Hoque SA; Islam MA; Rahman SR
    Virus Genes; 2017 Jun; 53(3):377-385. PubMed ID: 28401407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of a recent rise of dual amantadine-resistance mutations in the influenza A M2 sequence.
    Durrant MG; Eggett DL; Busath DD
    BMC Genet; 2015; 16 Suppl 2(Suppl 2):S3. PubMed ID: 25953496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009.
    Choi WY; Kim S; Lee N; Kwon M; Yang I; Kim MJ; Cheong SG; Kwon D; Lee JY; Oh HB; Kang C
    Antiviral Res; 2009 Nov; 84(2):199-202. PubMed ID: 19720085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.
    Nguyen HT; Fry AM; Gubareva LV
    Antivir Ther; 2012; 17(1 Pt B):159-73. PubMed ID: 22311680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of amantadine-resistant H3N2 avian influenza A virus in South Korea.
    Lee J; Song YJ; Park JH; Lee JH; Baek YH; Song MS; Oh TK; Han HS; Pascua PN; Choi YK
    J Clin Microbiol; 2008 Nov; 46(11):3788-90. PubMed ID: 18845822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.